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Spinal cord disease in HIV infection.
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Introduction

Hypothesis
Human microglial mice can be used to study peripheral neuropathy and spinal cord
myelopathy in HIV infection
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To study HIV in its relation to spinal cord disease, we used a recently developed
humanized mouse model that has human microglial cell reconstitution. This model
allows for the HIV infection in central nervous system and the observation of
resulting pathology.

Humanized mouse model
Immune deficient NOD/Scid IL2Rg-/- (NOG) mice when transplanted with human
CD34+ hematopoietic stem cells (HSC) at birth develop complete human immune
system that can be studied for the life of the mouse.
When the cytokine human Interleukin-34 (IL-34) was introduced transgenically
into NOG mice, human microglia were spontaneously developed in the mouse
brain of HSC transplanted humanized mice.
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Myelin loss in the HIV infected SC
A. Immunohistology staining for HIV-1 infected microglial cells (top HIV RNA, bottom HIV-1p24,
brown) in different brain regions (Cerebellum, CB; Cortex, CTX; Hippocampus, HC). B. Plasma
viral RNA levels at 3 and 6 weeks post infection, C. Brain viral RNA levels measured by realtime PCR in IL34-NOG microglial mice.
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HIV infection in the spinal cord
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Human microglia in mouse brain
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Immunohistology staining for glial fibrillary acidic protein (GFAP, brown) to assess astrogliosis.
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HIV infection is associated with numerous spinal cord diseases, such as vacuolar
myelopathy, primary HIV-associated acute transverse myelitis, and primary CNS
lymphoma, amongst others. These diseases had a much higher prevalence in the
pre-cART era, however, some individuals are still affected despite cART
treatment. Moreover, a previous study has shown that HIV-1 gp120 induces
synaptic degeneration in the spinal pain neural circuit, which is likely a critical step
in neuropathogenesis of the spinal cord in HIV. Further study is needed to better
understand how HIV patients are affected by spinal cord disease, and to develop
therapeutic strategies.

Glial activation in the HIV-infected SC
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A. Immunofluorescence staining for Myelin
associated glycoprotein (MAG, Red) and
human microglia (HLA-DR, green) from
control and HIV mice. B. Quantification of
MAG fluorescence intensity captured by
multispectral imaging.
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Conclusion and Future Directions
• This is the first demonstration of human microglial reconstitution and productive
HIV infected in a mouse spinal cord.
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• HIV infection resulted in myelin loss in the anterior column white matter.
• Further analysis of glial activation in the grey matter and demyelination in different
regions of SC and the resulting consequences in behavioral phenotype needs to
be evaluated.
• Studying SC disease in the human microglial mice during combination
antiretrovirally (cART) suppressed HIV infection will provide a means to understand
the disease in people living with HIV (PLWH).
• The new mouse model can be used to study the mechanisms underlying the
pathology, discover therapeutic targets and for therapeutic testing.
Mathews et al. Molecular Neurodegeneration, 2019

A. Immunohistology staining of brain and different tissues for human microglia and
macrophages (HLA-DR, brown) in humanized NSG. And IL-34-NOG mice. Human microglia are
present only in humanized IL34-NOG mice. B. Human cells in mouse brain had typical
microglial morphology.

A. Spinal cord HIV RNA levels measured by droplet digital PCR (DDPCR). B. Immunohistology
staining for human microglia (HLA-DR, brown). Bottom panels show multi-nucleated giant cells
that are typical pathological feature I. HIV infection. HIV-1 infected microglial cells (HIV-1p24,
brown) are also present at significant levels.
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